Search Results 2061-2070 of 17582 for Fertility Basics
Phase 1 Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Splicing Modulator H3B-8800 for Subjects With Myelodysplastic Syndromes, Acute ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
About this study. The purpose of this study is to evaluate patterns of and changes in secretion levels of the stress hormone, cortisol and other steroid ...
Regorafenib is a type of drug called a kinase inhibitor. Regorafenib interferes with how some kinase proteins work. Some of these kinases in cancer cells might ...
About this study. The purpose of the study is to see whether lung concentrations of iron and a protein that binds iron are influenced by the presence of ...
Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread. Participation eligibility. Participant ...
Specifically, identify a robust pre-treatment marker that predicts a high rate of major pathologic response to the least toxic neoadjuvant immunotherapy regimen ...
A Phase 1 dose-escalation study designed to evaluate the safety, tolerability, and preliminary efficacy of anito-cel in subjects with generalized myasthenia ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!